Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group (Q44267568)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group |
scientific article |
Statements
1 reference
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group (English)
1 reference
Opal SM
1 reference
Fisher CJ Jr
1 reference
Dhainaut JF
1 reference
Vincent JL
1 reference
Brase R
1 reference
Lowry SF
1 reference
Sadoff JC
1 reference
Slotman GJ
1 reference
Levy H
1 reference
Balk RA
1 reference
Shelly MP
1 reference
Pribble JP
1 reference
LaBrecque JF
1 reference
Lookabaugh J
1 reference
Donovan H
1 reference
Dubin H
1 reference
Baughman R
1 reference
Norman J
1 reference
DeMaria E
1 reference
Matzel K
1 reference
Abraham E
1 reference
Seneff M
1 reference
1 reference
Identifiers
1 reference